Abstract 4553: The CD25 antibody RG6292 selectively depletes Tregs while preserving IL-2 signaling and CTL activity for tumor control
Amann, Maria, Schnetzler, Gabriel, Theresa, Kolben, Solomon, Isabelle, Boetsch, Christophe, Marrer-Berger, Estelle, Flury, Reto, Murgia, Claudio, Karanikas, Vaios, Sam, Johannes, Sutmuller, Roger, Eckmann, Jan, Koll, Hans, Belli, Sara, Vargas, Frederic Arce, Zervas, Dimitrios, Qing, Chen, Brown, Mark A., Salimu, Josephine, Goubier, Anne, Neumann, Sebastian, Peggs, Karl S., Quezada, Sergio A.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article